---
figid: PMC5415836__11658_2016_2_Fig2_HTML
figtitle: Following TLR2-ligand interaction a signaling pathway is started using MYD88
  as an adaptor molecule
organisms:
- NA
pmcid: PMC5415836
filename: 11658_2016_2_Fig2_HTML.jpg
figlink: /pmc/articles/PMC5415836/figure/Fig2/
number: F2
caption: Following TLR2-ligand interaction a signaling pathway is started using MYD88
  as an adaptor molecule. The signaling pathway leads to the activation of several
  transcription factors, including NF-kB, MAPK and AP-1, and subsequently cell activation.
  Adapted from Bagheri et al. []
papertitle: Toll-like receptor 2 and type 2 diabetes.
reftext: Zahra Sepehri, et al. Cell Mol Biol Lett. 2016;21:2.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8900247
figid_alias: PMC5415836__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5415836__F2
ndex: 54baeb14-df13-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5415836__11658_2016_2_Fig2_HTML.html
  '@type': Dataset
  description: Following TLR2-ligand interaction a signaling pathway is started using
    MYD88 as an adaptor molecule. The signaling pathway leads to the activation of
    several transcription factors, including NF-kB, MAPK and AP-1, and subsequently
    cell activation. Adapted from Bagheri et al. []
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TLR2
  - MYD88
  - IRAK4
  - IRAK1
  - IRAK2
  - TAB1
  - TRAF6
  - MAP3K7
  - NR2C2
  - CRK
  - MAPK14
  - MAPK1
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK8
  - MAPK9
  - MAPK10
  - JUN
  - FOS
  - FOSB
  - JUNB
  - JUND
  - MAPK3
---
